Metronidazole

This classification denotes a trichomonacide agent and protein synthesis inhibitor with the molecular formula C6H9N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 140QMO216E, chemically known as 1h-imidazole-1-ethanol, 2-methyl-5-nitro- but generally known as metronidazole, which bears US NIH Compound Identifier 4173. European Medicines Agency schedules Metronidazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08922MIG. The term METRONIDAZOLE is an International Non-Proprietary Name. World Health Organization schedules metronidazole in its Anatomical Therapeutic Chemical (ATC) Classification. METRONIDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule metronidazole under HS 29332990 and SITC 51573. As of Q4 2014, METRONIDAZOLE remains the US FDA Preferred Term for this commodity. Metronidazole bears US NLM identifiers UMLS ID C0025872 and NCI Concept Code C651. SMILES: OCCN1C(NCC1[N](=O)O)C.